| LA | |
|---|---|
| Post | - |
| Pre | - |
| M1 | M2 | M3 | M4 | M5 | M6 | M7 | M8 | M9 | M10 | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | - | - | - | 0.4 | 2.3 | 142.9 | 103.1 | 14.2 | 0.1 | - | 262.9 |
| 1 | - | - | - | - | - | 29.5 | 40.6 | 1.5 | - | - | 71.6 |
| LO1 | LO2 | LO3 | LO4 | LO5a | LO5b | LO6 | Total | |
|---|---|---|---|---|---|---|---|---|
| Post | - | - | - | - | - | - | 42.7 | 42.7 |
| Pre | - | - | - | - | - | - | 28.5 | 28.5 |
| AME | |
|---|---|
| 0 | 1.5 |
| 1 | 2.7 |
| LOP1 | LOP2 | LOP3 | LOP4 | Total | |
|---|---|---|---|---|---|
| Post | - | - | - | - | - |
| Pre | - | - | - | - | - |
| central brain | |
|---|---|
| 0 | 26.9 |
| 1 | 34.5 |
| Number of post synapses: | 4470 |
| Number of pre synapses: | 1218 |
| Number of output connections: | 3068 |
| Coverage factor: | 3.2 |
| Columnar completeness: | 0.45 |
| Area completeness: | 0.47 |
| Cell size (columns): | 80 |
| Number of post synapses: | 726 |
| Number of pre synapses: | 485 |
| Number of output connections: | 1552 |
| Coverage factor: | 2.5 |
| Columnar completeness: | 0.12 |
| Area completeness: | 0.15 |
| Cell size (columns): | 13 |
| Number of post synapses: | 0 |
| Number of pre synapses: | 0 |
| Number of output connections: | 0 |
| Coverage factor: | 0 |
| Columnar completeness: | 0 |
| Area completeness: | 0 |
| Cell size (columns): | 0 |
| instance | NT | total connections | connections /#MeVP14 (R) | % | % cumu. | |
|---|---|---|---|---|---|---|
| 0 | Cm4 (R) | Glu | 1,263 | 74.3 | 22.4% | 22.4% |
| 1 | Cm9 (R) | Glu | 476 | 28.0 | 8.4% | 30.8% |
| 2 | LoVP96 (R) | Glu | 368 | 21.6 | 6.5% | 37.3% |
| 3 | Dm2 (R) | ACh | 294 | 17.3 | 5.2% | 42.6% |
| 4 | MeLo3b (R) | ACh | 243 | 14.3 | 4.3% | 46.9% |
| 5 | Cm1 (R) | ACh | 209 | 12.3 | 3.7% | 50.6% |
| 6 | Mi10 (R) | ACh | 190 | 11.2 | 3.4% | 53.9% |
| 7 | Cm31b (R) | GABA | 158 | 9.3 | 2.8% | 56.7% |
| 8 | MeLo6 (R) | ACh | 149 | 8.8 | 2.6% | 59.4% |
| 9 | Cm7 (R) | Glu | 141 | 8.3 | 2.5% | 61.9% |
| 10 | MeVPLo2 (L) | ACh | 137 | 8.1 | 2.4% | 64.3% |
| 11 | MeVP12 (R) | ACh | 134 | 7.9 | 2.4% | 66.7% |
| 12 | MeVPLo2 (R) | ACh | 125 | 7.4 | 2.2% | 68.9% |
| 13 | MeTu1 (R) | ACh | 110 | 6.5 | 1.9% | 70.8% |
| 14 | aMe8 (R) | ACh | 79 | 4.6 | 1.4% | 72.2% |
| 15 | MeVC2 (L) | ACh | 79 | 4.6 | 1.4% | 73.6% |
| 16 | aMe5 (R) | ACh | 73 | 4.3 | 1.3% | 74.9% |
| 17 | Li14 (R) | Glu | 49 | 2.9 | 0.9% | 75.8% |
| 18 | MeVP14 (R) | ACh | 44 | 2.6 | 0.8% | 76.6% |
| 19 | MeTu4c (R) | ACh | 41 | 2.4 | 0.7% | 77.3% |
| 20 | Cm34 (R) | Glu | 38 | 2.2 | 0.7% | 78.0% |
| 21 | aMe17b (R) | GABA | 37 | 2.2 | 0.7% | 78.6% |
| 22 | Dm8a (R) | Glu | 35 | 2.1 | 0.6% | 79.3% |
| 23 | MeVP46 (R) | Glu | 31 | 1.8 | 0.5% | 79.8% |
| 24 | MeVC27 (L) | unclear | 29 | 1.7 | 0.5% | 80.3% |
| 25 | Cm3 (R) | GABA | 27 | 1.6 | 0.5% | 80.8% |
| 26 | MeTu3a (R) | ACh | 26 | 1.5 | 0.5% | 81.3% |
| 27 | Mi15 (R) | ACh | 26 | 1.5 | 0.5% | 81.7% |
| 28 | MeLo5 (R) | ACh | 24 | 1.4 | 0.4% | 82.2% |
| 29 | Pm9 (R) | GABA | 24 | 1.4 | 0.4% | 82.6% |
| 30 | aMe12 (R) | ACh | 23 | 1.4 | 0.4% | 83.0% |
| 31 | MeTu3b (R) | ACh | 23 | 1.4 | 0.4% | 83.4% |
| 32 | MeTu3c (R) | ACh | 23 | 1.4 | 0.4% | 83.8% |
| 33 | MeVC21 (R) | Glu | 21 | 1.2 | 0.4% | 84.2% |
| 34 | MeVP62 (R) | ACh | 21 | 1.2 | 0.4% | 84.5% |
| 35 | Cm20 (R) | GABA | 20 | 1.2 | 0.4% | 84.9% |
| 36 | Cm25 (R) | Glu | 20 | 1.2 | 0.4% | 85.3% |
| 37 | Tm36 (R) | ACh | 20 | 1.2 | 0.4% | 85.6% |
| 38 | Dm8b (R) | Glu | 19 | 1.1 | 0.3% | 85.9% |
| 39 | MeVC24 (R) | Glu | 19 | 1.1 | 0.3% | 86.3% |
| 40 | MeVP29 (R) | ACh | 19 | 1.1 | 0.3% | 86.6% |
| 41 | Pm4 (R) | GABA | 18 | 1.1 | 0.3% | 86.9% |
| 42 | Cm24 (R) | Glu | 17 | 1.0 | 0.3% | 87.2% |
| instance | NT | total connections | connections /#MeVP14 (R) | % | % cumu. | |
|---|---|---|---|---|---|---|
| 0 | MeVC20 (R) | Glu | 1,017 | 59.8 | 18.2% | 18.2% |
| 1 | Cm4 (R) | Glu | 482 | 28.4 | 8.6% | 26.8% |
| 2 | Cm5 (R) | GABA | 355 | 20.9 | 6.3% | 33.1% |
| 3 | MeVC21 (R) | Glu | 347 | 20.4 | 6.2% | 39.3% |
| 4 | aMe8 (R) | ACh | 299 | 17.6 | 5.3% | 44.7% |
| 5 | Cm8 (R) | GABA | 285 | 16.8 | 5.1% | 49.8% |
| 6 | MeVC22 (R) | Glu | 266 | 15.6 | 4.8% | 54.5% |
| 7 | Cm28 (R) | unclear | 201 | 11.8 | 3.6% | 58.1% |
| 8 | Cm27 (R) | Glu | 182 | 10.7 | 3.3% | 61.4% |
| 9 | LoVP96 (R) | Glu | 148 | 8.7 | 2.6% | 64.0% |
| 10 | aMe26 (R) | ACh | 107 | 6.3 | 1.9% | 65.9% |
| 11 | Cm16 (R) | Glu | 104 | 6.1 | 1.9% | 67.8% |
| 12 | aMe30 (R) | Glu | 100 | 5.9 | 1.8% | 69.6% |
| 13 | 5thsLNv_LNd6 (R) | ACh | 79 | 4.6 | 1.4% | 71.0% |
| 14 | aMe24 (R) | unclear | 78 | 4.6 | 1.4% | 72.4% |
| 15 | Cm6 (R) | GABA | 66 | 3.9 | 1.2% | 73.6% |
| 16 | Cm3 (R) | GABA | 63 | 3.7 | 1.1% | 74.7% |
| 17 | Lat1 (R) | unclear | 63 | 3.7 | 1.1% | 75.8% |
| 18 | MeVP15 (R) | ACh | 62 | 3.6 | 1.1% | 76.9% |
| 19 | l-LNv (R) | unclear | 50 | 2.9 | 0.9% | 77.8% |
| 20 | MeLo3b (R) | ACh | 48 | 2.8 | 0.9% | 78.7% |
| 21 | MeVC24 (R) | Glu | 44 | 2.6 | 0.8% | 79.4% |
| 22 | MeVP14 (R) | ACh | 44 | 2.6 | 0.8% | 80.2% |
| 23 | aMe13 (R) | unclear | 40 | 2.4 | 0.7% | 81.0% |
| 24 | Tm37 (R) | Glu | 39 | 2.3 | 0.7% | 81.6% |
| 25 | MeVP62 (R) | ACh | 38 | 2.2 | 0.7% | 82.3% |
| 26 | aMe4 (R) | ACh | 34 | 2.0 | 0.6% | 82.9% |
| 27 | Cm21 (R) | GABA | 28 | 1.6 | 0.5% | 83.4% |
| 28 | LC27 (R) | ACh | 28 | 1.6 | 0.5% | 83.9% |
| 29 | LoVP72 (R) | ACh | 26 | 1.5 | 0.5% | 84.4% |
| 30 | MeTu3b (R) | ACh | 25 | 1.5 | 0.4% | 84.8% |
| 31 | aMe9 (R) | ACh | 23 | 1.4 | 0.4% | 85.3% |
| 32 | LoVP50 (R) | ACh | 23 | 1.4 | 0.4% | 85.7% |
| 33 | LoVP9 (R) | unclear | 22 | 1.3 | 0.4% | 86.1% |
| 34 | Tm36 (R) | ACh | 21 | 1.2 | 0.4% | 86.4% |
| 35 | MeVPMe11 (R) | Glu | 19 | 1.1 | 0.3% | 86.8% |
| 36 | Mi17 (R) | GABA | 19 | 1.1 | 0.3% | 87.1% |
| 37 | MeLo6 (R) | ACh | 18 | 1.1 | 0.3% | 87.4% |
| 38 | MeVP29 (R) | ACh | 18 | 1.1 | 0.3% | 87.8% |
| 39 | SLP249 (R) | unclear | 18 | 1.1 | 0.3% | 88.1% |
| 40 | Cm9 (R) | Glu | 17 | 1.0 | 0.3% | 88.4% |
| 41 | LoVP16 (R) | ACh | 17 | 1.0 | 0.3% | 88.7% |